One of these things is not like the others: The idea of precedence in health technology assessment and coverage decisions

Milbank Quarterly

Volumn 83, Issue 2, 2005, Pages 193-223

  Giacomini, Mita ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Ethics; Resource allocation; Social values; Technology assessment

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CANADA; DECISION MAKING; ECONOMICS; ETHICS; GENETIC SCREENING; HEALTH CARE AND PUBLIC HEALTH; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MALE; METHODOLOGY; REVIEW; SOCIAL PSYCHOLOGY; STANDARD;

HEALTH CARE AND PUBLIC HEALTH;

CANADA; DECISION MAKING; GENETIC SCREENING; HEALTH CARE RATIONING; HUMANS; INSURANCE, HEALTH; MALE; SOCIAL VALUES; SPERM INJECTIONS, INTRACYTOPLASMIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 22344450275     PISSN: 0887378X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-0009.2005.00344.x     Document Type: Review

References (60)

1. Akanmidu, R. A. 2001. The Morality of Precedent in Law. Ratio Juris 14(2):244-51.
2. Aronovitch, H. 1997. The Political Importance of Analogical Argument. Political Studies 45:78-92.
3. Arras, J.D. 1991. Getting Down to Cases: The Revival of Casuistry in Bioethics. Journal of Medicine and Philosophy 16:29-51.
4. Atkinson, T. 2002. Lifestyle Drug Market Booming. Nature Medicine 8(9):909.
5. Banks, C.P. 1999. Reversals of Precedent and Judicial Policy-Making: How Judicial Conceptions of Stare Decisis in the U.S. Supreme Court Influence Social Change. Akron Law Review 32(2):233-58.
6. Baylis, F., and J.S. Robert. (forthcoming) Radical Rupture: Exploring Biological Sequelae of Germ-Line Genetic Intervention. In A Dividing Line? Toward an Ethics of Germline Gene Therapy, edited by J.E.J. Rasko, G.M. O'Sullivan, and R.A. Ankeny. Cambridge: Cambridge University Press.
7. Calltorp, J. 1999. Priority Setting in Health Policy in Sweden and a Comparison with Norway. Health Policy 50(1-2):1-22.
8. Cameron and Smith v. Nova Scotia. 1999. Nova Scotia Court of Appeal.
9. Commission on the Future of Health Care in Canada. 2002. Building on Values: The Future of Health Care in Canada. Saskatoon.
10. Copi, I.M. 1986. Analogy. In Informal Logic, by I.M. Copi, 167-96. New York: Macmillan.
11. Creinin, M.D., R. Lisman, and R.C. Strickler. 1999. Screening for Factor V Leiden Mutation before Prescribing Combination Oral Contraceptives. Fertility and Sterility 72(4):646-51.
12. Daniels, N., and J.E. Sabin. 1997. Limits to Health Care: Fair Procedures, Democratic Deliberation, and the Legitimacy Problem for Insurers. Philosophy and Public Affairs 4:303-50.
13. Daniels, N., and J.E. Sabin. 2002. Accountability for Reasonableness. In Setting Limits Fairly; Can We Learn to Share Medical Resources? by N. Daniels and J.E. Sabin, 43-66. New York: Oxford University Press.
14. Daniels, N., J.R. Teagarden, and J.E. Sabin. 2003. An Ethical Template for Pharmacy Benefits. Health Affairs 22(1): 125-37.
15. Deber, R., E. Ross, and M. Catz. 1994. Comprehensiveness in Health Care: Report to the HEAL Action Lobby. Toronto: University of Toronto, Department of Health Administration.
16. D.R. and L.R., B.C. and L.A.C., B.L. and R.F., L.E. and M.E.J.H. and K.H. v. Ontario. 1998. Ontario Health Services Appeal Board.
17. Eisenhower, J.J. III. 1988. Four Theories of Precedent and Its Role in Judicial Decisions. Temple Law Review 61:871-7.
18. Fletcher, C.E. III. 1988. Judicial Dialectics. Cumberland Law Review 19(1):97-197.
19. Giacomini, M., F. Miller, and G. Browman. 2002. Confronting the "Grey Zones" of Technology Assessment: Evaluating Genetic Testing Services for Public Insurance Coverage in Canada. International Journal of Technology Assessment in Health Care 19(2):301-15.
20. Government Committee on Choices in Health Care. 1992. Choices in Health Care. Zoetermeer (Netherlands): Ministry of Welfare, Health and Social Affairs.
21. Grann, V.R., W. Whang, J.S. Jacobson, D.F. Heitjan, K.H. Antman, and A.I. Neugut. 1999. Benefits and Costs of Screening Ashkenazi Jewish Women for BRCA1 and BRCA2. Journal of Clinical Oncology 17(2):494-500.
22. Gutmann, A., and D. Thompson. 2002. Just Deliberation about Health Care. In Ethical Dimensions of Health Policy, edited by M. Danis, C. Clancy, and L.R. Churchill, 77-96. New York: Oxford University Press.
23. Hansson, L., O. Norheim, and K. Ruyter. 1994. Equality, Explicitness, Severity, and Rigidity: The Oregon Plan Evaluated from a Scandinavian Perspective. Journal of Medicine and Philosophy 19:343-66.
24. Haslam, D. 1998. Viagra and Penicillin: The Same Problem? The Practitioner 242:725.
25. Hirth, R.A., M.E. Chernew, E. Miller, A.M. Fendrick, and W.G. Weissert. 2000. Willingness to Pay for a Quality-Adjusted Life Year: In Search of a Standard. Medical Decision Making 20(3):332-42.
26. Hitchcock, D. 1992. Reasoning by Analogy: A General Theory. In The Generalizability of Critical Thinking: Multiple Perspectives on an Educational Ideal, edited by S.P. Norris, 109-24. New York: Teachers College Press.
27. Hjortsberg, C., and O. Ghatnekar. 2001. Health Care Systems in Transition: Sweden. European Observatory on Health Care Systems 3(8):1-97.
28. Hofstadter, D. 1996a. Fluid Concepts and Creative Analogies: Computer Models of the Fundamental Mechanisms of Thought. New York: Basic Books.
29. Hofstadter, D. 1996b. Variations on a Theme as the Crux of Creativity. In Metamagical Themas: Questing for the Essence of Mind and Pattern, by D. Hofstadter, 232-59. New York: Basic Books.
30. Holyoak, K.J., and P. Thagard. 1995. Mental Leaps: Analogy in Creative Thought. Cambridge, Mass.: MIT Press.
31. Hurley, J., J.L. Cosby, M. Giacomini, and B. Hutchison. 2000. Making Resource Allocation Decisions in the Health Care Sector: A Review of Some Recent Proposals. Saskatoon: HEALNet Regionalization Research Centre.
32. Jonsen, A.R. 1991. Of Balloons and Bicycles, or, the Relationship between Ethical Theory and Practical Judgment. Hastings Center Report, September/October, 14-16.
33. Jonsen, A.R. 1995a. Casuistry: An Alternative or Complement to Principles? Kennedy Institute of Ethics Journal 5(3):237-51.
34. Jonsen, A.R. 1995b. The Weight and Weighing of Ethical Principles. In The Ethics of Research Involving Human Subjects: Facing the 21st Century, edited by H.Y. Vanderpool, 59-82. Frederick, Md.: University Publishing Group.
35. Jonsen, A.R., and S. Toulmin. 1988a. The Abuse of Casuistry. Berkeley: University of California Press.
36. Jonsen, A.R., and S. Toulmin. 1988b. The Achievement of Casuistry. In The Abuse of Casuistry, by A.R. Jonsen and S. Toulmin, 250-65. Berkeley: University of California Press.
37. Keith, A. 2000. The Economics of Viagra. Health Affairs 19(2):147-57.
38. King, C.H., D.F. Fischler, and R.D. Gerkin. 2002. Will Genetic Testing Alter the Management of Disease Caused by Infectious Agents? A Cost-Effectiveness Analysis of Gene-Testing Strategies for Prevention of Rheumatic Fever. Clinical Infectious Diseases 34(11):1491-9.
39. Kwok, Y.S., and C. Kim. 1999. Valuing Viagra: What Is Restoring Potency Worth? Effective Clinical Practice 2(4):171-5.
40. Miller, R.B. 1996a. Casuistry and Modern Ethics. Chicago: University of Chicago Press.
41. Miller, R.B. 1996b. Casuistry, Politics, and Moral Complexity. In Casuistry and Modern Ethics, by R.B. Miller, 3-16. Chicago: University of Chicago Press.
42. Parens, E. 1998. An Immodest Proposal. Hastings Center Report 28(3):44.
43. Phillips, K.A., J. Spetz, and J.S. Haas. 2003. Viagra and Contraceptives. Health Affairs 22(1):277.
44. Reuzel, R.P.B., G.J. van der Wilt, H.A.M.J. ten Have, and P.F de Vries Robbe. 1999. Reducing Normative Bias in Health Technology Assessment: Interactive Evaluation and Casuistry. Medicine, Health Care and Philosophy 2:255-63.
45. Reuzel, R.P.B., G.J. van der Wilt, H.A.M.J. ten Have, and P.F. de Vries Robbe. 2001. Interactive Technology Assessment and Wide Reflective Equilibrium. Journal of Medicine and Philosophy 2001(3):245-61.
46. Rifkin, J. 2001. Precedent Is "Double Sided." Amherst, Mass.: University of Massachusetts Press.
47. Schauer, F. 1987. Precedent. Stanford Law Review 39:571-605.
48. Schauer, F. 1991. Rules and Law. In Playing by the Rules: A Philosophical Examination of Rule-Based Decision-Making in Law and in Life, by F. Schauer, 167-206. Oxford: Clarendon Press.
49. Schauer, F. 1995. Giving Reasons. Stanford Law Review 47:633-59.
50. Schlesinger, M., and R. Lau. 2000. The Meaning and Measure of Policy Metaphors. American Political Science Review 94(3):611-26.
51. Seay, G. 2002. Theory Skepticism and Moral Dilemmas. Kennedy Institute of Ethics Journal 12(3):279-98.
52. Senate Standing Committee on Social Affairs Science and Technology. 2002. Recommendations for Reform. Vol. 6 of The Health of Canadians - The Federal Role. Ottawa: Thirty-seventh Parliament of Canada.
53. Smith, K.J., and M.S. Roberts. 2000. The Cost-Effectiveness of Sildenafil. Annals of Internal Medicine 132(12):933-7.
54. Stolk, E.A., J.J. Busschbach, M. Caffa, E.J. Meuleman, and F.F. Rutten. 2000. Cost Utility Analysis of Sildenafil Compared with Papaverine-Phentolamine Injections. British Medical Journal 320(7243):1165-8.
55. Stone, D. 1998. Policy Paradox: The Art of Political Decision Making. New York: Norton.
56. Sunstein, C.R. 1993. Commentary: On Analogical Reasoning. Harvard Law Review 106:741-91.
57. Titlow, K., L. Randel, C.M. Clancy, and E.J. Emanuel. 2000. Drug Coverage Decisions: The Role of Dollars and Values. Health Affairs 19(2):240-7.
58. Wildes, K. 2000. After Paradigms: The Crisis of Secular Casuistry. In Moral Acquaintances: Methodology in Bioethics, by K. Wildes, 86-121. South Bend, Ind.: University of Notre Dame Press.
59. Wildhagen, M.F., H.B. Hilderink, J.G. Verzijl, J.B. Verheij, L. Kooij, T. Tijmstra, L.P. ten Kate, and J.D. Habbema. 1998. Costs, Effects, and Savings of Screening for Cystic Fibrosis Gene Carriers. Journal of Epidemiology and Community Health 52(7):459-67.
60. Wilson, R., M.S. Rowan, and J. Henderson. 1995. Core and Comprehensive Health Care Services: 1. Introduction to the Canadian Medical Association's Decision-Making Framework. Canadian Medical Association Journal 152:10636.